Historical Company Announcements

Historic NASDAQ News Releases

Historic ASX Company Announcements

DateDescriptionView
Jul 21, 2023IHL Submit IND Application for IHL42x
Jul 18, 2023Fortrea to Manage IHL FDA IND Phase 2 and 3 Clinical Trial
Jul 13, 2023IHL Receives HREC Approval Ph 2 Clinical Trial for IHL675
Jul 10, 2023IHL Intends to Redomicile to US & List all Shares on Nasdaq
Jul 10, 2023Updated IHL Intends to Redomicile to US announcement – SID
Jul 6, 2023IHL Receives Ethics Approval BA – BE Clinical Trial
Jun 30, 2023Change of Director’s Interest Notice
Jun 26, 2023Change of Registered Office
Jun 23, 2023IHL Announcement – H.C. Wainwright Virtual Conference
Jun 16, 2023Principal Investigators Appointed for IHL42X Phase 2-3 Trial
Showing 31 to 40 of 1128 announcements
1 2 3 4 5 6 … 113

Historical results and presentations

Incannex intention to redomicile to US
OSA Announcement
Psychennex Company Update May 2023

Investor inquiries

For investor related enquiries please contact
Brad Dilkes: investors@incannex.com.au

Media inquiries

For press and media related enquiries please contact
Joel Latham: admin@incannex.com.au

Subscribe and stay connected

Stay up to date with Incannex’s leading research and development programs, multiple secondary assets, investor relations and biotechnology advancements.

"*" indicates required fields